참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Creatine | HCID 586 | — |
| 반응물 | Pyruvic Acid | HCID 1060 | — |
| 반응물 | Pyruvate | HCID 107735 | — |
| 반응물 | Sodium | HCID 5360545 | — |
| 반응물 | Pyruvoylglycine | HCID 6451625 | — |
| 반응물 | Calcium pyruvate | HCID 9859191 | — |
| 반응물 | Magnesium pyruvate | HCID 10219827 | — |
| 반응물 | Sodium pyruvate | HCID 23662274 | — |
| 반응물 | Propanoic acid, 2-oxo-, potassium salt (1:1) | HCID 23678876 | — |
| 반응물 | HCID 131721533 | HCID 131721533 | — |
| 용매 | Acetic Acid | HCID 176 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Creatine | HCID 586 | — |
| 생성물 | HCID 178513022 | HCID 178513022 | — |
반응 단계
Pyruvic acid is a colorless liquid with an odor resembling that of acetic acid and has a melting point of 13° C. Pyruvic acid is an intermediate in the breakdown of sugars to alcohol by yeast. The mineral salts of pyruvic acid, such as magnesium pyruvate, potassium pyruvate or calcium pyruvate or mixtures thereof are useful in the present invention. Sodium pyruvate is not especially preferred as it is known that sodium is associated with various negative medical conditions such as high blood pressure, water retention and heart disease. Further, certain athletes, such as bodybuilders, desire to present a defined visual image of their body which shows muscle definition and thus, the water retention properties of the sodium salt are not beneficial. Pyruvate precursors in the form of pyruvamides or pyruvyl-amino acids are also useful in the present invention. Pyruvyl-glycine is representative of the useful pyruvyl-amino acids. Another form of pyruvate precursor is pyruvyl-creatine, wherein pyruvate is bonded to creatine either covalently or ionically. Creatine or methylguanidineacetic acid has the chemical formula: ##STR2## and is present in the muscle tissue of vertebrates. It plays an important part in the cycle of chemical changes involving muscular contraction. Normally, creatine is the form in which creatine is excreted. Creatine is formed in the body by the methylation (by methionine) of glycocyamine.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06008252 |
|---|
| 출처 데이터셋 | uspto-grants-1999_12 |
|---|
| ORD ID | ord-3c45540003774589824d60aeb4717e18 |
|---|
| 출처 메모 | uspto-grants-1999_12 |
|---|